{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T20:10:20Z","timestamp":1783109420634,"version":"3.54.6"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82104018"],"award-info":[{"award-number":["82104018"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82473782"],"award-info":[{"award-number":["82473782"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82073318"],"award-info":[{"award-number":["82073318"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.ejmech.2024.117139","type":"journal-article","created":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T17:25:07Z","timestamp":1733505907000},"page":"117139","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Design, synthesis, and antitumor evaluation of quinazoline-4-tetrahydroquinoline chemotypes as novel tubulin polymerization inhibitors targeting the colchicine site"],"prefix":"10.1016","volume":"283","author":[{"given":"Qinhuai","family":"Lai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengyong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruofei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leyan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiran","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Mo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jifa","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lantu","family":"Gou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2024.117139_bib1","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/s41580-018-0009-y","article-title":"Microtubule dynamics: an interplay of biochemistry and mechanics","volume":"19","author":"Brouhard","year":"2018","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ejmech.2024.117139_bib2","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1007\/PL00000837","article-title":"Microtubule dynamics","volume":"58","author":"Valiron","year":"2001","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.ejmech.2024.117139_bib3","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/s41580-020-0214-3","article-title":"The tubulin code and its role in controlling microtubule properties and functions","volume":"21","author":"Janke","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ejmech.2024.117139_bib4","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.tcb.2018.08.003","article-title":"The tubulin detyrosination cycle: function and enzymes","volume":"29","author":"Nieuwenhuis","year":"2019","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.ejmech.2024.117139_bib5","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ejmech.2014.09.051","article-title":"Recent developments in tubulin polymerization inhibitors: an overview","volume":"87","author":"Kaur","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.117139_bib6","doi-asserted-by":"crossref","first-page":"14840","DOI":"10.1021\/acs.jmedchem.0c01345","article-title":"SAR investigation and discovery of water-soluble 1-Methyl-1,4-dihydroindeno[1,2-c]pyrazoles as potent tubulin polymerization inhibitors","volume":"63","author":"Cui","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.117139_bib7","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.tcb.2018.05.001","article-title":"Microtubule-targeting agents: strategies to hijack the cytoskeleton","volume":"28","author":"Steinmetz","year":"2018","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.ejmech.2024.117139_bib8","doi-asserted-by":"crossref","first-page":"13331","DOI":"10.1002\/anie.202100273","article-title":"Comprehensive analysis of binding sites in tubulin","volume":"60","author":"Muhlethaler","year":"2021","journal-title":"Angew Chem. Int. Ed. Engl."},{"key":"10.1016\/j.ejmech.2024.117139_bib9","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.ejmech.2019.03.025","article-title":"Anti-tubulin agents of natural origin: targeting taxol, vinca, and colchicine binding domains","volume":"171","author":"Naaz","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.117139_bib10","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1038\/nrd3253","article-title":"Microtubule-binding agents: a dynamic field of cancer therapeutics","volume":"9","author":"Dumontet","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2024.117139_bib11","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1158\/1535-7163.MCT-09-0366","article-title":"Microtubule inhibitors: differentiating tubulin-inhibiting agents based on mechanisms of action, clinical activity, and resistance","volume":"8","author":"Perez","year":"2009","journal-title":"Mol. Cancer Therapeut."},{"key":"10.1016\/j.ejmech.2024.117139_bib12","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/nrc2803","article-title":"Microtubules and resistance to tubulin-binding agents","volume":"10","author":"Kavallaris","year":"2010","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ejmech.2024.117139_bib13","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.4155\/fmc-2017-0100","article-title":"Tubulin inhibitors targeting the colchicine binding site: a perspective of privileged structures","volume":"9","author":"Li","year":"2017","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.ejmech.2024.117139_bib14","doi-asserted-by":"crossref","first-page":"839","DOI":"10.4155\/fmc-2020-0376","article-title":"Recent advances in research of colchicine binding site inhibitors and their interaction modes with tubulin","volume":"13","author":"Sun","year":"2021","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.ejmech.2024.117139_bib15","doi-asserted-by":"crossref","first-page":"12118","DOI":"10.1021\/acs.jmedchem.4c00878","article-title":"Discovery of novel diaryl-substituted fused heterocycles targeting katanin and tubulin with potent antitumor and antimultidrug resistance efficacy","volume":"67","author":"Jiang","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.117139_bib16","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2022.1040333","article-title":"Advances in antitumor research of CA-4 analogs carrying quinoline scaffold","volume":"10","author":"Wang","year":"2022","journal-title":"Front. Chem."},{"key":"10.1016\/j.ejmech.2024.117139_bib17","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.ejmech.2018.04.011","article-title":"Recent advances in trimethoxyphenyl (TMP) based tubulin inhibitors targeting the colchicine binding site","volume":"151","author":"Li","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.117139_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.113117","article-title":"Discovery of novel 2-aryl-3-sulfonamido-pyridines (HoAns) as microtubule polymerization inhibitors with potent antitumor activities","volume":"211","author":"Zhu","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.117139_bib19","doi-asserted-by":"crossref","DOI":"10.3390\/ph13010008","article-title":"Colchicine-binding site inhibitors from chemistry to clinic: a review","volume":"13","author":"McLoughlin","year":"2020","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ejmech.2024.117139_bib20","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.drudis.2021.12.001","article-title":"Molecular interactions at the colchicine binding site in tubulin: an X-ray crystallography perspective","volume":"27","author":"Wang","year":"2022","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejmech.2024.117139_bib21","doi-asserted-by":"crossref","first-page":"4360","DOI":"10.1016\/j.csbj.2021.07.039","article-title":"Application of ensemble pharmacophore-based virtual screening to the discovery of novel antimitotic tubulin inhibitors","volume":"19","author":"Gallego-Yerga","year":"2021","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"10.1016\/j.ejmech.2024.117139_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116543","article-title":"Dual-target inhibitors of colchicine binding site for cancer treatment","volume":"274","author":"Lu","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.117139_bib23","doi-asserted-by":"crossref","first-page":"2943","DOI":"10.1007\/s11095-012-0828-z","article-title":"An overview of tubulin inhibitors that interact with the colchicine binding site","volume":"29","author":"Lu","year":"2012","journal-title":"Pharm. Res. (N. Y.)"},{"key":"10.1016\/j.ejmech.2024.117139_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114660","article-title":"Recent advances in combretastatin A-4 codrugs for cancer therapy","volume":"241","author":"Guo","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.117139_bib25","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.637098","article-title":"The tubulin inhibitor VERU-111 in combination with vemurafenib provides an effective treatment of vemurafenib-resistant A375 melanoma","volume":"12","author":"Cui","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejmech.2024.117139_bib26","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s11060-012-0964-7","article-title":"Phase I trial of verubulin (MPC-6827) plus carboplatin in patients with relapsed glioblastoma multiforme","volume":"110","author":"Grossmann","year":"2012","journal-title":"J. Neuro Oncol."},{"key":"10.1016\/j.ejmech.2024.117139_bib27","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s11060-014-1437-y","article-title":"A phase 2 trial of verubulin for recurrent glioblastoma: a prospective study by the Brain Tumor Investigational Consortium (BTIC)","volume":"118","author":"Chamberlain","year":"2014","journal-title":"J. Neuro Oncol."},{"key":"10.1016\/j.ejmech.2024.117139_bib28","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1021\/acs.jmedchem.8b00028","article-title":"Radiosynthesis and in vivo evaluation of [(11)C]MPC-6827, the first brain penetrant microtubule PET ligand","volume":"61","author":"Kumar","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.117139_bib29","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.ejmech.2013.06.041","article-title":"N-aryl-6-methoxy-1,2,3,4-tetrahydroquinolines: a novel class of antitumor agents targeting the colchicine site on tubulin","volume":"67","author":"Wang","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.117139_bib30","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1021\/jm4016526","article-title":"Optimization of 4-(N-cycloamino)phenylquinazolines as a novel class of tubulin-polymerization inhibitors targeting the colchicine site","volume":"57","author":"Wang","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.117139_bib31","doi-asserted-by":"crossref","first-page":"5586","DOI":"10.1021\/acs.jmedchem.7b00273","article-title":"In vivo and mechanistic studies on antitumor lead 7-Methoxy-4-(2-methylquinazolin-4-yl)-3,4-dihydroquinoxalin-2(1H)-one and its modification as a novel class of tubulin-binding tumor-vascular disrupting agents","volume":"60","author":"Cui","year":"2017","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.117139_bib32","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1021\/acs.jmedchem.7b01858","article-title":"Heterocyclic-fused pyrimidines as novel tubulin polymerization inhibitors targeting the colchicine binding site: structural basis and antitumor efficacy","volume":"61","author":"Banerjee","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.117139_bib33","doi-asserted-by":"crossref","first-page":"2810","DOI":"10.1021\/acschembio.9b00696","article-title":"X-Ray crystal structure guided discovery and antitumor efficacy of dihydroquinoxalinone as potent tubulin polymerization inhibitors","volume":"14","author":"Arnst","year":"2019","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.ejmech.2024.117139_bib34","doi-asserted-by":"crossref","first-page":"13072","DOI":"10.1021\/acs.jmedchem.1c01202","article-title":"X-Ray crystallography-guided design, antitumor efficacy, and QSAR analysis of metabolically stable cyclopenta-pyrimidinyl dihydroquinoxalinone as a potent tubulin polymerization inhibitor","volume":"64","author":"Banerjee","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.117139_bib35","doi-asserted-by":"crossref","first-page":"3588","DOI":"10.1021\/acs.jmedchem.2c02115","article-title":"Design, synthesis, and biological evaluation of heterocyclic-fused pyrimidine chemotypes guided by X-ray crystal structure with potential antitumor and anti-multidrug resistance efficacy targeting the colchicine binding site","volume":"66","author":"Tan","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.117139_bib36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejmech.2013.10.058","article-title":"Novel 2-chloro-4-anilino-quinazoline derivatives as EGFR and VEGFR-2 dual inhibitors","volume":"71","author":"Barbosa","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.117139_bib37","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1021\/jm201494a","article-title":"Design, synthesis, and biological evaluation of new diaminoquinazolines as beta-catenin\/Tcf4 pathway inhibitors","volume":"55","author":"Mao","year":"2012","journal-title":"J. Med. Chem."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523424010213?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523424010213?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T18:59:44Z","timestamp":1741287584000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523424010213"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":37,"alternative-id":["S0223523424010213"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2024.117139","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis, and antitumor evaluation of quinazoline-4-tetrahydroquinoline chemotypes as novel tubulin polymerization inhibitors targeting the colchicine site","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2024.117139","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117139"}}